Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain

被引:180
|
作者
Callen, Lucia [1 ,2 ]
Moreno, Estefania [1 ,2 ]
Barroso-Chinea, Pedro [2 ,3 ]
Moreno-Delgado, David [1 ,2 ]
Cortes, Antoni [1 ,2 ]
Mallol, Josefa [1 ,2 ]
Casado, Vicent [1 ,2 ]
Luis Lanciego, Jose [2 ,3 ]
Franco, Rafael [3 ]
Lluis, Carmen [1 ,2 ]
Canela, Enric I. [1 ,2 ]
McCormick, Peter J. [1 ,2 ]
机构
[1] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain
[2] Univ Navarra, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Pamplona 31008, Spain
[3] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain
关键词
RAT PINEAL-GLAND; ARYLALKYLAMINE N-ACETYLTRANSFERASE; NEURAL PROGENITOR PROLIFERATION; PROXIMITY LIGATION ASSAY; ENDOCANNABINOID SYSTEM; ADENOSINE A(2A); RETINOIC ACID; HUMAN NEUROBLASTOMA; NUCLEUS-ACCUMBENS; MICROGLIAL CELLS;
D O I
10.1074/jbc.M111.335273
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected neuronal cells and in rat brain pineal gland, nucleus accumbens, and globus pallidus. Within CB1-CB2 receptor heteromers expressed in a neuronal cell model, agonist co-activation of CB1 and CB2 receptors resulted in a negative cross-talk in Akt phosphorylation and neurite outgrowth. Moreover, one specific characteristic of CB1-CB2 receptor heteromers consists of both the ability of CB1 receptor antagonists to block the effect of CB2 receptor agonists and, conversely, the ability of CB2 receptor antagonists to block the effect of CB1 receptor agonists, showing a bidirectional cross-antagonism phenomenon. Taken together, these data illuminate the mechanism by which CB2 receptors can negatively modulate CB1 receptor function.
引用
收藏
页码:20851 / 20865
页数:15
相关论文
共 50 条
  • [1] Pharmacology of cannabinoid CB1 and CB2 receptors
    Pertwee, RG
    PHARMACOLOGY & THERAPEUTICS, 1997, 74 (02) : 129 - 180
  • [2] Anterior segment CB1 and CB2 cannabinoid receptors
    Song, ZH
    Jiang, J
    Hemesath, A
    McCloud, C
    Zhong, L
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1157 - U1157
  • [3] Novel cannabinol probes for CB1 and CB2 cannabinoid receptors
    Mahadevan, A
    Siegel, C
    Martin, BR
    Abood, ME
    Beletskaya, I
    Razdan, RK
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) : 3778 - 3785
  • [4] CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
    Clayton, N
    Marshall, FH
    Bountra, C
    O'Shaughnessy, CT
    PAIN, 2002, 96 (03) : 253 - 260
  • [5] Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors
    Merighi, Stefania
    Simioni, Carolina
    Gessi, Stefania
    Varani, Katia
    Borea, Pier Andrea
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (03) : 471 - 477
  • [6] Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors
    Govaerts, SJ
    Muccioli, GG
    Hermans, E
    Lambert, DM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 495 (01) : 43 - 53
  • [7] CB1 and CB2 cannabinoid receptors are implicated in inflammatory hypersensitivity to pain
    Clayton, NM
    O'Shaughnessy, CT
    Marshall, F
    Bountra, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134
  • [8] Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses
    Gobira, P. H.
    Joca, S. R.
    Moreira, F. A.
    ACTA NEUROPSYCHIATRICA, 2024, 36 (02) : 67 - 77
  • [9] Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors
    Ding, Z
    Cowan, A
    Rawls, SM
    BRAIN RESEARCH, 2005, 1065 (1-2) : 147 - 151
  • [10] Pharmacological characterization of novel ligands for CB1 and CB2 cannabinoid receptors
    Thermos, K.
    Papazoglou, M.
    Antoniou, K.
    Mastrodimou, N.
    Panagis, G.
    Vlachou, S.
    Renieri, E.
    Nahmias, V.
    Menissiou, A.
    Gianni, M.
    Kondylis, M. P.
    Daifoti-Papadopoulou, Z.
    Papahatjis, D.
    Spyraki, C.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 394 - 395